Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
The drug is tested on Providencia stuartii strain: ATCC25827 for biotransformation. The drug concentrations were measured before and after a 12-h incubation by liquid-chromatography-coupled mass spectrometry (LC?MS)
Assay data:227 Tested
SummaryPubMed Citation
Antibacterial activity against Providencia stuartii
Assay data:2 Tested
Antibacterial activity against Providencia stuartii assessed as inhibition of bacterial growth incubated for 18 hrs by p-iodonitrotetrazolium chloride dye based colorimetric assay
Assay data:1 Tested
Antibacterial activity against Providencia stuartii incubated for 24 hrs by visual inspection
Antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 70 clinical isolate up to 512 mg/L by broth microtiter dilution method
Summary
Antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 67 clinical isolate up to 512 mg/L by broth microtiter dilution method
Potentiation of meropenem-induced antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 70 clinical isolate at 1:8 meropenem:compound ratio by checkerboard method
Potentiation of meropenem-induced antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 67 clinical isolate at 1:8 meropenem:compound ratio by checkerboard method
Potentiation of meropenem-induced antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 70 clinical isolate assessed as MIC of meropenem at 1:8 meropenem:compound ratio by broth microtiter dilution method
Potentiation of meropenem-induced antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 67 clinical isolate assessed as MIC of meropenem at 1:8 meropenem:compound ratio by broth microtiter dilution method
Antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 70 clinical isolate by broth microtiter dilution method
Antibacterial activity against VIM1 carbapenemase producing multidrug-resistant Providencia stuartii 67 clinical isolate by broth microtiter dilution method
In vitro antibacterial activity against cephalosporins-resistant Providencia stuartii assessed as growth inhibition after 17 hrs by serial two-fold dilution technique
Antibacterial activity against Providencia stuartii after 17 hrs by serial two fold dilution method
Assay data:12 Tested
Antibacterial activity against aminoglycoside-resistant Providencia stuartii expressing ANT(2')-1 by broth microdilution method
Assay data:4 Tested
Antimicrobial activity against Providencia stuartii Ps5 expressing beta-lactamase PER-1 by Etest
Assay data:5 Tested
Antimicrobial activity against Providencia stuartii Ps5 expressing beta-lactamase PER-1 by disk diffusion method
Antimicrobial activity against Proteus stuartii by broth microdilution method
Antimicrobial activity against Providencia stuartii clinical isolate after 18 to 22 hrs by broth microdilution method in presence of beta-lactamase inhibitor BLI-489
Antimicrobial activity against Providencia stuartii clinical isolate after 18 to 22 hrs by broth microdilution method in presence of beta-lactamase inhibitor Tazobactam
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on